GEC-ESTRO ACROP prostate brachytherapy guidelines

A Henry, BR Pieters, FA Siebert, P Hoskin - Radiotherapy and Oncology, 2022 - Elsevier
This is an evidence-based guideline for prostate brachytherapy. Throughout levels of
evidence quoted are those from the Oxford Centre for Evidence based Medicine …

[HTML][HTML] Polyethylene glycol-based hydrogel rectal spacers for prostate brachytherapy: a systematic review with a focus on technique

S Vaggers, BP Rai, ECP Chedgy, A de la Taille… - World Journal of …, 2021 - Springer
Introduction Radiation dose to the rectum in prostate brachytherapy (PBT) can be reduced
by the use of polyethylene glycol (PEG) hydrogel spacers. This reduces the rate of rectal …

COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigation

VM Williams, JM Kahn, MM Harkenrider, J Chino… - Brachytherapy, 2020 - Elsevier
Purpose The purpose of this study was to highlight the importance of timely brachytherapy
treatment for patients with gynecologic, breast, and prostate malignancies, and provide a …

Ultrahypofractionation should be a standard of care option for intermediate-risk prostate cancer

A Loblaw - Clinical Oncology, 2020 - Elsevier
Conclusion UHF using older technology has been shown in one large RCT to be non-
inferior to conventionally fractionated EBRT for failure-free survival and equal in terms of late …

Prostate high dose-rate brachytherapy as monotherapy for prostate cancer: late toxicity and patient reported outcomes from a randomized phase II clinical trial

M Corkum, A Loblaw, Y Hasan, HT Chung… - Radiotherapy and …, 2021 - Elsevier
Abstract Background and Purpose Long-term toxicity of high dose-rate brachytherapy as
monotherapy for prostate cancer is not well defined. We report late toxicity and health …

Prostate cancer brachytherapy: SFRO guidelines 2021

P Pommier, M Ferré, P Blanchard, É Martin… - Cancer …, 2022 - Elsevier
Prostate brachytherapy techniques are described, concerning both permanent seed implant
and high dose rate brachytherapy. The following guidelines are presented: brachytherapy …

[HTML][HTML] Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer

M Moll, A Renner, C Kirisits, C Paschen… - Strahlentherapie und …, 2021 - Springer
Purpose This study's objective was the comparison of external beam radiotherapy (EBRT)
and I‑125 seed brachytherapy regarding clinical outcome and development of side effects …

Complications and side effects of high-dose-rate prostate brachytherapy

K Martell, MA Kollmeier - Brachytherapy, 2021 - Elsevier
Purpose To describe technical challenges and complications encountered during and after
high-dose-rate prostate brachytherapy (HDR-BT) and review management of these …

Towards real time in-vivo rectal dosimetry during trans-rectal ultrasound based high dose rate prostate brachytherapy using MOSkin dosimeters

J Poder, A Howie, R Brown, J Bucci… - Radiotherapy and …, 2020 - Elsevier
Purpose To compare the dose measured by MOSkin dosimeters coupled to a trans-rectal
ultrasound (TRUS) probe to the dose predicted by the brachytherapy treatment planning …

High dose rate brachytherapy in high-risk localised disease–why do anything else?

GC Morton, SM Alrashidi - Clinical Oncology, 2020 - Elsevier
The management of high-risk prostate cancer is challenging, as patients have a high risk of
both local and distant relapse. Although adjuvant systemic treatment remains an important …